SEC Says CBD Exec Defrauded Hospital Of $13M During COVID

The U.S. Securities and Exchange Commission filed a new complaint against the former chief executive officer of a pain management and cannabidiol products company, alleging that he tricked a hospital into...

Already a subscriber? Click here to view full article